- ホーム
- > 洋書
- > 英文書
- > Business / Economics
Full Description
Emerging Paradigms in Delivery Systems for Antitubercular Therapy provides an up-to-date and thorough overview of the state-of-the-art of concepts, design, and recent advances in nanomedicines and nanobiotechnology-based strategies for the treatment of tuberculosis. The book enables researchers to prepare a variety of nanotechnology-based strategies, investigate their properties, and discover their uses and applications in antitubercular therapy, focusing on advanced nanomaterials that are utilized for encapsulation of nucleic acid, mRNA, DNA, and tuberculosis vaccination.
This book covers all major topics that have shaped the development of nanomedicine and propelled it to its current place at the forefront of Nanotechnology based treatment innovation. It will be a welcomed resource for researchers and readers with more and more challenging therapy and biologicals with their possible modifications to be used for the effective therapy of tuberculosis.
Contents
1. Introduction: An Overview of Novel Approaches for the Treatment of Tuberculosis
2. Theragnostic Approaches for the Management of Tuberculosis
3. Role of Inorganic Nanoparticles for the Treatment of Tuberculosis
4. Role of Polymeric Nanoparticles for the Treatment of Tuberculosis
5. Role of Vesicular Carriers for the Treatment of Tuberculosis
6. Polymeric Micelles in Therapy of Tuberculosis
7. Herbal Approaches for the Treatment of Tuberculosis
8. Role of Gut-lung axis in Tuberculosis
9. Mucoadhesive Drug Delivery System(s) for the Treatment of Tuberculosis
10. Current Gene Therapy Approaches for the Treatment of Tuberculosis
11. Novel Targets and Drugs for the Treatment of Tuberculosis
12. Targeting Inflammation and Oxidative Stress for the Treatment of Tuberculosis
13. Potential Approaches for the Treatment of Drug-resistant Tuberculosis
14. Targeted Drug Delivery to the Macrophagic Cellular Tropics in Tuberculosis
15. Combination Antitubercular Therapy Using Nanomedicine to Treat and Eradicate Tuberculosis
16. Tuberculosis Vaccines: Advancements and Ongoing Clinical Trials
17. Future Prospects and Regulatory Aspects for the Management of Tuberculosis
